Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EDEM2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
mRNA | POLD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ZNF589 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | CYTH3 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | EFEMP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | CAPN2 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | AC009065.1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | NONO | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |